Cargando…
Interpreting Adverse Signals in Diabetes Drug Development Programs
Detection and interpretation of adverse signals during preclinical and clinical stages of drug development inform the benefit-risk assessment that determines suitability for use in real-world situations. This review considers some recent signals associated with diabetes therapies, illustrating the d...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687324/ https://www.ncbi.nlm.nih.gov/pubmed/23695817 http://dx.doi.org/10.2337/dc13-0182 |